Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 126-150 of 686 matching filings.

Per page
25
Current page
6
3

3

Filing date
25 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
25 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
17 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFN14A File 001-13341

DEFN14A

Filing date
25 Jul 2022
Reporting date
25 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRRN14A File 001-13341

PRRN14A

Filing date
22 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREN14A File 001-13341

PREN14A

Filing date
14 Jul 2022
Reporting date
13 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-13341

DFAN14A

Filing date
11 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
08 Jul 2022
Reporting date
06 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
08 Jul 2022
Reporting date
06 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-46083

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
09 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-46083

THE SCHEDULE 13D

Filing date
25 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-262614

424B2

Filing date
05 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262614

EFFECT filing

Filing date
04 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .